CooperVision's MiSight® 1 day contact lenses (IMAGE)

McDougall Communications

CooperVision's MiSight® 1 day contact lenses

Caption

Investigators followed 144 children as part of a multi-site, randomized, controlled clinical trial for CooperVision's MiSight® 1 day contact lenses, which are currently available in 26 countries with more expected this year.

Credit

CooperVision, Inc.

Usage Restrictions

None

License

Licensed content

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.